| | 
Part, Chapter, Paragraph
1 II, 8. 2. 1| Straetmans, van Schrojenstein Lantman-de Valk et al 2007).~Further,
2 II, 8. 2. 1| levels (van Schrojenstein Lantman-de Valk and Walsh, in press).
3 II, 8. 2. 1| Straetmans, van Schrojenstein Lantman-de Valk et al (2007) presented
4 II, 8. 2. 1| H.M.J. van Schrojenstein Lantman-de Valk, F.G. Schellevis, G.
5 II, 8. 2. 1| eurohealthnet.eu>~Van Schrojenstein Lantman-de Valk HMJ, Linehan C, Kerr
6 II, 8. 2. 1| 427-434.~van Schrojenstein Lantman-de Valk HMJ, Walsh PN (in press):
7 II, 8. 2. 1| Kerr M.P, van Schrojenstein Lantman-de Valk HMJ (2003): Health
8 II, 8. 2. 1| Kerr, M., van Schrojenstein Lantman-de Valk, H., Buono, S., Azema,
|
|
| |
